While iron deficiency is the leading cause of failure to respond to treatment with EPO; it must not be forgotten that active inflammatory or infectious processes can temporarily block the response to iron therapy and, thereby, to EPO [12–14]. The gene discussed is EPO; the disease is nutritional disorder.